The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey
about
Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screeningImaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitationsAbility of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancer(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer.Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey.Positron emission mammography (PEM): reviewing standardized semiquantitative methodIs There Use for FDG-PET in Prostate Cancer?Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals.Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees.Fluorodeoxyglucose positron emission tomography may aid the diagnosis of aggressive primary prostate cancer: A case series study.Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.Clinical significance of patterns of increased [18F]-FDG uptake in the thyroid gland: a pictorial review.FDG PET/CT allowing detection and follow-up of tumor cell transplantation.Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.
P2860
Q33599546-CDA6B9DF-6874-45B3-A64A-BA6CBDA0B3C2Q34035683-8E895B93-4F3D-4E12-8B99-626B2003A7EEQ34223171-F61A4910-6D8D-4042-BED1-B2633127036DQ34987693-1F15336F-9666-4423-B7FA-A433EB61C5A6Q35625394-B225AB2F-12A1-4786-A459-9AE7F20540A5Q36502692-4C9C9BBB-7694-4A2F-BD2C-93194E41BEEBQ37077347-E61AFE26-EB42-4606-8482-E54B581D1773Q37314333-3C7F297A-31EA-438F-BC03-62E1B3D27E6CQ39003083-E79B5E85-A16B-4908-BA45-A37F8654BF53Q39883690-2FB02823-BB0E-450E-9991-A8DD5438C50EQ41485060-E030B2C6-F345-44E6-8CDE-AD7854E4DF2DQ41852965-4FED0DAF-E02E-429A-A866-B75A7146B36BQ45382138-EBC456B5-6A90-454E-848E-51619EE63041Q48191350-E0FBCDCD-A0B0-4706-BF24-8217494C207CQ49564362-DCD5FC6B-67FD-40EC-98F1-26D5227438EDQ52986602-DB5C04B3-8D31-49F6-8EC1-B1181895D49AQ53078145-5A05B029-9D3C-44FE-B464-5F54C01B499BQ55279829-932A1504-56B8-466D-B5C3-EF18CC9A08B8
P2860
The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The current status of an FDG-P ...... (2006-2009) nationwide survey
@ast
The current status of an FDG-P ...... (2006-2009) nationwide survey
@en
type
label
The current status of an FDG-P ...... (2006-2009) nationwide survey
@ast
The current status of an FDG-P ...... (2006-2009) nationwide survey
@en
prefLabel
The current status of an FDG-P ...... (2006-2009) nationwide survey
@ast
The current status of an FDG-P ...... (2006-2009) nationwide survey
@en
P2093
P2860
P1476
The current status of an FDG-P ...... (2006-2009) nationwide survey
@en
P2093
Eriko Tsukamoto
Hiroshi Fukuda
Hiroshi Iwata
Kazuhiro Oguchi
Kimiichi Uno
Michio Senda
Rumi Nakashima
Ryogo Minamimoto
Sadahiko Nishizawa
Seishi Jinnouchi
P2860
P2888
P356
10.1007/S12149-012-0660-X
P577
2012-10-20T00:00:00Z